Local production of pharmaceuticals is emerging as a key priority for African nations, spurred by the Covid-19 pandemic. The report finds that Special Economic Zones can boost local manufacturing by aligning investor needs, enhancing medicine access, and engaging essential stakeholders.
Local production of medicines is a topic that has become a priority for many African countries, especially since the Covid-19 pandemic. This report finds that Special Economic Zones (SEZs) can help improve the business case for local pharmaceutical production in Africa provided due attention is paid to meeting the needs of pharmaceutical investors, structuring the SEZ to address local access to medicines and by engaging key stakeholders.